Drug intelligence / Profile preview

4-[(1S,2S,5S)-5-(hydroxymethyl)-8-methyl-3-oxabicyclo[3.3.1]non-7-en-2-yl]phenol

Development stage
Unknown
Modality
Small Molecules
01

Overview

4-[(1S,2S,5S)-5-(hydroxymethyl)-8-methyl-3‑oxabicyclo[3.3.1]non‑7‑en‑2‑yl]phenol is a synthetic small molecule with the molecular formula C16H20O3 and a molecular weight of approximately 260.33 g/mol[1][6]. It is classified as a phenolic compound due to its phenol moiety and features a complex bicyclic structure with defined stereochemistry[9]. The compound has been cataloged in chemical databases such as PubChem (CID: 6852154), DrugBank (DB07086), and ChEMBL (CHEMBL193676)[1][6][3]. It is considered an experimental drug and has not received regulatory approval for any indication; there are no reported clinical trials or approved uses as of the latest updates[3][8]. Its mechanism of action and therapeutic potential remain uncharacterized in public sources.

Other names
4-((1S,2S,5S)-5-(hydroxymethyl)-8-methyl-3-oxabicyclo(3.3.1)non-7-en-2-yl)phenol

Beyond the preview

Go deeper on 4-[(1S,2S,5S)-5-(hydroxymethyl)-8-methyl-3-oxabicyclo[3.3.1]non-7-en-2-yl]phenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-[(1S,2S,5S)-5-(hydroxymethyl)-8-methyl-3-oxabicyclo[3.3.1]non-7-en-2-yl]phenol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call